home / stock / soly / soly news


SOLY News and Press, Soliton Inc. From 07/08/19

Stock Information

Company Name: Soliton Inc.
Stock Symbol: SOLY
Market: NYSE
Website: soliton.com

Menu

SOLY SOLY Quote SOLY Short SOLY News SOLY Articles SOLY Message Board
Get SOLY Alerts

News, Short Squeeze, Breakout and More Instantly...

SOLY - Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019

HOUSTON , July 8, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced ...

SOLY - Soliton Announces Filing of Form S-1 Registering the Shares Issued in Private Placement at $14.00 per Unit

HOUSTON , July 2, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...

SOLY - FOMO Rally Part Deux - Charting Goldman Sachs

I introduced the idea that "Fear Of Missing Out" driven trade was afoot this past Friday and got in depth in my Sunday piece. You might want to start with the Sunday piece first to get the most out of this note. We are in a "Goldilocks" moment, let's embrace it, even if it goes against our...

SOLY - Soliton Partners with Capital Laser and Skin Care to Advance Pivotal Cellulite Trial

HOUSTON , July 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today annou...

SOLY - Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today

HOUSTON , June 28, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - Soliton Engages CRO to begin Pivotal Cellulite Trial

HOUSTON , June 25, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today anno...

SOLY - The S&P 500 Is Rebalancing, Another Reason For Caution

S&P 500 Index Readjustment I paraphrased this information from Barron's, and inserted my own take as well.... On June 24, S&P Dow Jones Indices will readjust the representation of the 500 companies that constitute the market benchmark, a quarterly process known as rebalancing. Exch...

SOLY - Reg A+ IPOs Under Fire As Longfin Faces SEC Fraud Charges

Do you remember the bizarre story of Longfin ( OTCPK:LFIN ), a firm that purported to be a cryptocurrency tech firm? I wrote it up in LongFin: From $5 To $100+ In A Week As Crypto Mania Spreads in December 2017. In short, Longfin listed using the uncommon Reg A+ IPO method. That allowed it...

SOLY - Soliton announces $9.45M private placement

Soliton SOLY has entered into definitive agreements with certain institutional and accredited investors to raise aggregate gross proceeds of ~$9.45M through the private placement . More news on: Soliton, Inc., Read more ...

SOLY - Soliton Announces $9.45 Million Private Placement

HOUSTON , June 17, 2019 /PRNewswire/ -- Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has entered into defi...

Previous 10 Next 10